HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Musk xylene

This article was originally published in The Rose Sheet

Executive Summary

FDA is collecting samples of products containing the ingredient to determine the level present. The agency also is developing analytical methods to assess the risk to humans from exposure to the ingredient. The concern about musk xylene stems from testing in Germany that found traces of musk xylene in breast milk and fish, indicating that it may bioaccumulate ("The Rose Sheet," Nov. 15, p. 1) The Research Institute for Fragrance Materials (FIRM) has concluded that "musk xylene does not present any health risk as used in cosmetics." The ingredient, a synthetic musk fragrance, is used in household products and detergents as a fixative and masking agent in addition to being used in personal fragrances

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000128

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel